Identification and characterization of putative methylation targets in the MAOA locus using bioinformatic approaches

Epigenetics

Volumn 5, Issue 4, 2010, Pages 325-342

  Shumay, Elena ^a   Fowler, Joanna S ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Computational analysis; DNA methylation; Epigenetic potential; Epigenetic regulation; Human MAOA gene

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CYTOSINE; DNA; HISTONE; MESSENGER RNA; RNA POLYMERASE II; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; BIOINFORMATICS; BRAIN; BRAIN FUNCTION; COMPUTER MODEL; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; ENZYME ACTIVITY; EPIGENETICS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LIBRARY; GENE LOCUS; GENE NUMBER; GENE TARGETING; GENOMICS; GENOTYPE; HUMAN; HUMAN EXPERIMENT; HYPOTHESIS; NORMAL HUMAN; NUCLEOSOME; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN PROCESSING; REGULATORY MECHANISM; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 77954664179     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.5.4.11719     Document Type: Article

References (113)

1. Shih JC, Thompson RF. Monoamine oxidase in neuropsychiatry and behavior. Am J Hum Genet 1999; 65:593-8.
2. Stahl SM, Felker A. Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants. CNS Spectr 2008; 13:855-70.
3. Meyer JH, Ginovart N, Boovariwala A, Sagrati S, Hussey D, Garcia A, et al. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 2006; 63:1209-16.
4. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993; 262:578-80.
5. Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Pournin S, et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 1995; 268:1763-6.
6. Sabol SZ, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 1998; 103:273-9.
7. Buckholtz JW, Meyer-Lindenberg A. MAOA and the neurogenetic architecture of human aggression. Trends Neurosci 2008; 31:120-9.
8. Rosenberg S, Templeton AR, Feigin PD, Lancet D, Beckmann JS, Selig S, et al. The association of DNA sequence variation at the MAOA genetic locus with quantitative behavioural traits in normal males. Hum Genet. 2006; 120:447-59.
9. Balciuniene J, Emilsson L, Oreland L, Pettersson U, Jazin E. Investigation of the functional effect of monoamine oxidase polymorphisms in human brain. Hum Genet 2002; 110:1-7.
10. Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, et al. Role of genotype in the cycle of violence in maltreated children. Science 2002; 297:851-4.
11. Kim-Cohen J, Caspi A, Rutter M, Tomas MP, Moffitt TE. The caregiving environments provided to children by depressed mothers with or without an antisocial history. Am J Psychiatry 2006; 163:1009-18.
12. Wakschlag LS, Kistner EO, Pine DS, Biesecker G, Pickett KE, Skol AD, et al. Interaction of prenatal exposure to cigarettes and MAOA genotype in pathways to youth antisocial behavior. Mol Psychiatry 2009; In press.
13. Singh I, Rose N. Biomarkers in psychiatry. Nature 2009; 460:202-7.
14. Fowler JS, Alia-Klein N, Kriplani A, Logan J, Williams B, Zhu W, et al. Evidence That Brain MAO A Activity Does Not Correspond to MAO A Genotype in Healthy Male Subjects. Biol Psychiatry 2007; 62:355-8.
15. Kagami M, Sekita Y, Nishimura G, Irie M, Kato F, Okada M, et al. Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd(14)-like phenotypes. Nat Genet 2008; 40:237-42.
16. Vitalis T, Alvarez C, Chen K, Shih JC, Gaspar P, Cases O. Developmental expression pattern of monoamine oxidases in sensory organs and neural crest derivatives. J Comp Neurol 2003; 464:392-403.
17. Nicotra A, Falasca L, Senatori O, Conti Devirgiliis L. Monoamine oxidase A and B activities in embryonic chick hepatocytes: differential regulation by retinoic acid. Cell Biochem Funct 2002; 20:87-94.
18. Gartler SM, Riggs AD. Mammalian X-chromosome inactivation. Annu Rev Genet 1983; 17:155-90.
19. Heard E, Disteche CM. Dosage compensation in mammals: fine-tuning the expression of the X chromosome. Genes Dev 2006; 20:1848-67.
20. Auda GR, Kirk SH, Billett MA, Billett EE. Localization of Monoamine Oxidase mRNA in Human Placenta. J Histochem Cytochem 1998; 46:1393-400.
21. Rakyan VK, Down TA, Thorne NP, Flicek P, Kulesha E, Graf S, et al. An integrated resource for genomewide identification and analysis of human tissue-specific differentially methylated regions (tDMRs). Genome Res 2008; 18:1518-29.
22. Mann MR, Lee SS, Doherty AS, Verona RI, Nolen LD, Schultz RM, et al. Selective loss of imprinting in the placenta following preimplantation development in culture. Development 2004; 131:3727-35.
23. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 2006; 38:1378-85.
24. Pinsonneault JK, Papp AC, Sadee W. Allelic mRNA expression of X-linked monoamine oxidase a (MAOA) in human brain: dissection of epigenetic and genetic factors. Hum Mol Genet 2006; 15:2636-49.
25. Philibert RA, Gunter TD, Beach SR, Brody GH, Madan A. MAOA methylation is associated with nicotine and alcohol dependence in women. Am J Med Genet B Neuropsychiatr Genet 2008; 147:565-70.
26. Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat Rev 2008; 9:465-76.
27. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986; 321:209-13.
28. Saxonov S, Berg P, Brutlag DL. A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc Natl Acad Sci USA 2006; 103:1412-7.
29. Galm O, Herman JG, Baylin SB. The fundamental role of epigenetics in hematopoietic malignancies. Blood Rev 2006; 20:1-13.
30. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev 2007; 8:286-98.
31. Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987; 196:261-82.
32. Takai D, Jones PA. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci 2002; 99:3740-5.
33. Takai D, Jones PA. The CpG island searcher: a new WWW resource. In Silico Biol 2003; 3:235-40.
34. Gu H, Bock C, Mikkelsen TS, Jager N, Smith ZD, Tomazou E, et al. Genome-scale DNA methylation mapping of clinical samples at single-nucleotide resolution. Nat Methods 7:133-6.
35. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 2006; 38:1378-85.
36. Straussman R, Nejman D, Roberts D, Steinfeld I, Blum B, Benvenisty N, et al. Developmental programming of CpG island methylation profiles in the human genome. Nat Struct Mol Biol 2009; 16:564-71.
37. Han L, Zhao Z. CpG islands or CpG clusters: how to identify functional GC-rich regions in a genome? BMC Bioinformatics 2009; 10:65.
38. Su J, Zhang Y, Lv J, Liu H, Tang X, Wang F, et al. CpG_MI: a novel approach for identifying functional CpG islands in mammalian genomes. Nucleic Acids Res 2010; 38:6.
39. Previti C, Harari O, Zwir I, del Val C. Profile analysis and prediction of tissue-specific CpG island methylation classes. BMC Bioinformatics 2009; 10:116.
40. Bock C, Walter J, Paulsen M, Lengauer T. Interindividual variation of DNA methylation and its implications for large-scale epigenome mapping. Nucleic Acids Res 2008; 36:55.
41. Law JA, Jacobsen SE. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat Rev Genet 2010; 11:204-220.
42. Chapman RD, Heidemann M, Albert TK, Mailhammer R, Flatley A, Meisterernst M, et al. Transcribing RNA polymerase II is phosphorylated at CTD residue serine-7. Science 2007; 318:1780-2.
43. Tabach Y, Brosh R, Buganim Y, Reiner A, Zuk O, Yitzhaky A, et al. Wide-scale analysis of human functional transcription factor binding reveals a strong bias towards the transcription start site. PLoS ONE 2007; 2:807.
44. Marino-Ramirez L, Spouge JL, Kanga GC, Landsman D. Statistical analysis of over-represented words in human promoter sequences. Nucleic Acids Res 2004; 32:949-58.
45. Bock C, Walter J, Paulsen M, Lengauer T. CpG island mapping by epigenome prediction. PLoS Comput Biol 2007; 3:110.
46. Hackenberg M, Previti C, Luque-Escamilla PL, Carpena P, Martinez-Aroza J, Oliver JL. CpGcluster: a distance-based algorithm for CpG-island detection. BMC Bioinformatics 2006; 7:446.
47. Glass JL, Thompson RF, Khulan B, Figueroa ME, Olivier EN, Oakley EJ, et al. CG dinucleotide clustering is a species-specific property of the genome. Nucleic Acids Res 2007; 35:6798-807.
48. Ponger L, Mouchiroud D. CpGProD: identifying CpG islands associated with transcription start sites in large genomic mammalian sequences. Bioinformatics 2002; 18:631-3.
49. Illingworth R, Kerr A, DeSousa D, Jorgensen H, Ellis P, Stalker J, et al. A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol 2008; 6:37-51.
50. Carson MB, Langlois R, Lu H. Mining knowledge for the methylation status of CpG islands using alternating decision trees. Conf Proc IEEE Eng Med Biol Soc 2008; 2008:3787-90.
51. Fang F, Fan S, Zhang X, Zhang MQ. Predicting methylation status of CpG islands in the human brain. Bioinformatics 2006; 22:2204-9.
52. Boumber YA, Kondo Y, Chen X, Shen L, Guo Y, Tellez C, et al. An Sp1/Sp3 binding polymorphism confers methylation protection. PLoS Genet 2008; 4:1000162.
53. Guo G, Ou XM, Roettger M, Shih JC. The VNTR 2 repeat in MAOA and delinquent behavior in adolescence and young adulthood: associations and MAOA promoter activity. Eur J Hum Genet 2008; 16:626-34.
54. Legendre M, Pochet N, Pak T, Verstrepen KJ. Sequence-based estimation of minisatellite and microsatellite repeat variability. Genome Res 2007; 17:1787-96.
55. Lindahl Allen M, Koch CM, Clelland GK, Dunham I, Antoniou MN. DNA methylation-histone modification relationships across the desmin locus in human primary cells. BMC Mol Biol 2009; 10:51.
56. Wright JE, Mais C, Prieto JL, McStay B. A role for upstream binding factor in organizing ribosomal gene chromatin. Biochem Soc Symp 2006; 77-84.
57. Tshuikina M, Nilsson K, Oberg F. Positive histone marks are associated with active transcription from a methylated ICSBP/IRF8 gene. Gene 2008; 410:259-67.
58. Henikoff S. Nucleosomes at active promoters: unforgettable loss. Cancer Cell 2007; 12:407-9.
59. Jiang C, Pugh BF. Nucleosome positioning and gene regulation: advances through genomics. Nat Rev 2009; 10:161-72.
60. Tirosh I, Barkai N. Two strategies for gene regulation by promoter nucleosomes. Genome Res 2008; 18:1084-91.
61. Gal-Yam EN, Jeong S, Tanay A, Egger G, Lee AS, Jones PA. Constitutive nucleosome depletion and ordered factor assembly at the GRP78 promoter revealed by single molecule footprinting. PLoS Genet 2006; 2:160.
62. Choi JK, Kim YJ. Epigenetic regulation and the variability of gene expression. Nat Genet 2008; 40:141-7.
63. Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell 2007; 128:707-19.
64. Wang JP, Widom J. Improved alignment of nucleosome DNA sequences using a mixture model. Nucleic Acids Res 2005; 33:6743-55.
65. Lin JC, Jeong S, Liang G, Takai D, Fatemi M, Tsai YC, et al. Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island. Cancer Cell 2007; 12:432-44.
66. Radwan A, Younis A, Luykx P, Khuri S. Prediction and analysis of nucleosome exclusion regions in the human genome. BMC Genomics 2008; 9:186.
67. Gabdank I, Barash D, Trifonov EN. Nucleosome DNA bendability matrix (C. elegans). J Biomol Struct Dyn 2009; 26:403-11.
68. Crawford GE, Davis S, Scacheri PC, Renaud G, Halawi MJ, Erdos MR, et al. DNase-chip: a high-resolution method to identify DNase I hypersensitive sites using tiled microarrays. Nat Meth 2006; 3:503-9.
69. Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, Tilghman SM. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 2000; 405:486-9.
70. Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 2004; 32:91-4.
71. Chen K. Organization of MAO A and MAO B promoters and regulation of gene expression. Neurotoxicology 2004; 25:31-6.
72. Shih JC, Chen K. Regulation of MAO-A and MAO-B gene expression. Curr Med Chem 2004; 11:1995-2005.
73. Robertson G, Bilenky M, Lin K, He A, Yuen W, Dagpinar M, et al. cisRED: a database system for genome-scale computational discovery of regulatory elements. Nucleic Acid Res 2006; 34:68-73.
74. Frith MC, Li MC, Weng Z. Cluster-Buster: Finding dense clusters of motifs in DNA sequences. Nucleic Acid Res 2003; 31:3666-8.
75. Ferretti V, Poitras C, Bergeron D, Coulombe B, Robert F, Blanchette M. PReMod: a database of genome-wide mammalian cis-regulatory module predictions. Nucleic Acid Res 2007; 35:122-6.
76. Paeschke K, Simonsson T, Postberg J, Rhodes D, Lipps HJ. Telomere end-binding proteins control the formation of G-quadruplex DNA structures in vivo. Nat Struct Mol Biol 2005; 12:847-54.
77. Yadav VK, Abraham JK, Mani P, Kulshrestha R, Chowdhury S. QuadBase: genome-wide database of G4 DNA-occurrence and conservation in human, chimpanzee, mouse and rat promoters and 146 microbes. Nucleic Acids Res 2008; 36:381-5.
78. Schonhoft JD, Bajracharya R, Dhakal S, Yu Z, Mao H, Basu S. Direct experimental evidence for quadruplex-quadruplex interaction within the human ILPR. Nucleic Acids Res 2009; 37:3310-20.
79. Ou TM, Lu YJ, Zhang C, Huang ZS, Wang XD, Tan JH, et al. Stabilization of G-quadruplex DNA and downregulation of oncogene c-myc by quindoline derivatives. J Med Chem 2007; 50:1465-74.
80. Kikin O, D'Antonio L, Bagga PS. QGRS Mapper: a web-based server for predicting G-quadruplexes in nucleotide sequences. Nucleic Acids Res 2006; 34:676-82.
81. Halder K, Wieland M, Hartig JS. Predictable suppression of gene expression by 5'-UTR-based RNA quadruplexes. Nucl Acids Res 2009; 37:6811-7.
82. Ciavatta D, Kalantry S, Magnuson T, Smithies O. A DNA insulator prevents repression of a targeted X-linked transgene but not its random or imprinted X inactivation. Proc Natl Acad Sci USA 2006; 103:9958-63.
83. Filippova GN, Cheng MK, Moore JM, Truong JP, Hu YJ, Nguyen DK, et al. Boundaries between chromosomal domains of X inactivation and escape bind CTCF and lack CpG methylation during early development. Dev Cell 2005; 8:31-42.
84. Levy S, Hannenhalli S, Workman C. Enrichment of regulatory signals in conserved non-coding genomic sequence. Bioinformatics 2001; 17:871-7.
85. Portales-Casamar E, Arenillas D, Lim J, Swanson MI, Jiang S, McCallum A, et al. The PAZAR database of gene regulatory information coupled to the ORCA toolkit for the study of regulatory sequences. Nucleic Acids Res 2009; 37:54-60.
86. Inoue-Murayama M, Mishima N, Hayasaka I, Ito S, Murayama Y. Divergence of ape and human monoamine oxidase A gene promoters: comparative analysis of polymorphisms, tandem repeat structures and transcriptional activities on reporter gene expression. Neurosci Lett 2006; 405:207-11.
87. Thierry-Mieg D, Thierry-Mieg J. AceView: a comprehensive cDNA-supported gene and transcripts annotation. Genome Biol 2006; 7:1-4.
88. Prestridge DS. Computer software for eukaryotic promoter analysis. Meth Mol Biol 2000; 130:265-95.
89. Knudsen S. Promoter2.0: for the recognition of PolII promoter sequences. Bioinformatics 1999; 15:356-61.
90. Solovyev V, Kosarev P, Seledsov I, Vorobyev D. Automatic annotation of eukaryotic genes, pseudogenes and promoters. Genome Biol 2006; 7:1-2.
91. Linhoff MW, Wright KL, Ting JP. CCAAT-binding factor NF-Y and RFX are required for in vivo assembly of a nucleoprotein complex that spans 250 base pairs: the invariant chain promoter as a model. Mol Cell Biol 1997; 17:4589-96.
92. Yang C, Bolotin E, Jiang T, Sladek FM, Martinez E. Prevalence of the initiator over the TATA box in human and yeast genes and identification of DNA motifs enriched in human TATA-less core promoters. Gene 2007; 389:52-65.
93. Khuu P, Ho PS. A rare nucleotide base tautomer in the structure of an asymmetric DNA junction. Biochemistry 2009; 48:7824-32.
94. Wang X, Xuan Z, Zhao X, Li Y, Zhang MQ. High-resolution human core-promoter prediction with CoreBoost_HM. Genome Res 2009; 19:266-75.
95. Barski A. High-resolution profiling of histone methylations in the human genome. Cell 2007; 129:823-37.
96. Gregory SG, Barlow KF, McLay KE, Kaul R, Swarbreck D, Dunham A, et al. The DNA sequence and biological annotation of human chromosome 1. Nature 2006; 441:315-21.
97. Di Rienzo A, Hudson RR. An evolutionary framework for common diseases: the ancestral-susceptibility model. Trends Genet 2005; 21:596-601.
98. Khuu P, Sandor M, DeYoung J, Ho PS. Phylogenomic analysis of the emergence of GC-rich transcription elements. Proc Natl Acad Sci USA 2007; 104:16528-33.
99. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009; 41:178-86.
100. Vinogradov AE. Dualism of gene GC content and CpG pattern in regard to expression in the human genome: magnitude versus breadth. Trends Genet 2005; 21:639-43.
101. Valen E, Pascarella G, Chalk A, Maeda N, Kojima M, Kawazu C, et al. Genome-wide detection and analysis of hippocampus core promoters using DeepCAGE. Genome Res 2009; 19:255-65.
102. Cheong J, Yamada Y, Yamashita R, Irie T, Kanai A, Wakaguri H, et al. Diverse DNA methylation statuses at alternative promoters of human genes in various tissues. DNA Res 2006; 13:155-67.
103. Ioshikhes IP, Zhang MQ. Large-scale human promoter mapping using CpG islands. Nat Genet 2000; 26:61-3.
104. Muse GW, Gilchrist DA, Nechaev S, Shah R, Parker JS, Grissom SF, et al. RNA polymerase is poised for activation across the genome. Nat Genet 2007; 39:1507-11.
105. Kelly MA, Mijovic CH, Barnett AH. Genetics of type 1 diabetes. Best Pract Res Clin Endocrinol Metab 2001; 15:279-91.
106. Breen G, Collier D, Craig I, Quinn J. Variable number tandem repeats as agents of functional regulation in the genome. IEEE Eng Med Biol Mag 2008; 27:103-8.
107. Brockschmidt FF, Nothen MM, Hillmer AM. The two most common alleles of the coding GGN repeat in the androgen receptor gene cause differences in protein function. J Mol Endocrinol 2007; 39:1-8.
108. Mignone F, Grillo G, Licciulli F, Iacono M, Liuni S, Kersey PJ, et al. UTRdb and UTRsite: a collection of sequences and regulatory motifs of the untranslated regions of eukaryotic mRNAs. Nucleic Acids Res 2005; 33:141-6.
109. Mueller WC, von Deimling A. Gene regulation by methylation. Recent results in cancer research Fortschritte der Krebsforschung 2009; 171:217-39.
110. Herranz M, Esteller M. New therapeutic targets in cancer: the epigenetic connection. Clin Transl Oncol 2006; 8:242-9.
111. Cheong J, Yamada Y, Yamashita R, Irie T, Kanai A, Wakaguri H, et al. Diverse DNA methylation statuses at alternative promoters of human genes in various tissues. DNA Res 2006; 13:155-67.
112. Turner JD, Pelascini LP, Macedo JA, Muller CP. Highly individual methylation patterns of alternative glucocorticoid receptor promoters suggest individualized epigenetic regulatory mechanisms. Nucleic Acids Res 2008; 36:7207-18.
113. Candiloro IL, Dobrovic A. Detection of MGMT promoter methylation in normal individuals is strongly associated with the T allele of the rs16906252 MGMT promoter single nucleotide polymorphism. Cancer Prev Res 2009; 2:862-7.